AdaptHealth Corp 2025年季度报告

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financialaccounting standards provided pursuant to Section 13(a) of the Exchange Act.o Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YesoNoxAs of May2, 2025, there were134,947,901shares of the Registrant’s Common Stock issued and outstanding. ADAPTHEALTH CORP. FORM 10-QTABLE OF CONTENTS PART I FINANCIAL INFORMATION Item 1. Interim Consolidated Financial Statements (Unaudited)Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2025 and 2024 Item 2. Unregistered Sales of Equity Securities and Use of ProceedsItem 3. Defaults upon Senior Securities 1 CAUTIONARY STATEMENT In this Quarterly Report on Form 10-Q, including “Management’s Discussion and Analysis of Financial Condition and Results ofOperations” inPart I Item 2, and the documents incorporated by reference herein, we make forward-looking statements within the meaning ofthe Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations for future financial performance,business strategies or expectations for our business. These statements may be preceded by, followed by or include the words “may,” “might,”“will,” “will likely result,” “should,” “estimate,” “plan,” “project,” “forecast,” “intend,” “expect,” “anticipate,” “believe,” “seek,” “continue,” risks and uncertainties which may cause them to turn out to be wrong. Accordingly, forward-looking statements should not be relied upon asrepresenting our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflectevents or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may berequired under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, our actual results orperformance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could causeactual results to differ include: •the possibility that we may be adversely affected by other economic, business, and/or competitive factors; •changes in applicable laws or regulations; and •other risks and uncertainties set forth in this Form 10-Q. Investorsshould carefully consider the foregoing factors and the other risks and uncertainties that may affect our business includingthose outlined under Item 1A, Risk Factors, in our most recent annual report on Form 10-K and our quarterly reports on Form 10-Q. 2 Operating lease obligationsOperating liabilities Net cash provided by operating activitiesPurchases of equipment and other fixed assets Repayments on long-term debt and lines of creditProceeds from borrowings on lines of credit Repayments of finance lease obligations(3,221)Proceeds from the exercise of stock options—Proceeds received in connection with employee stock purchase plan564Payments relating to the Tax Receivable Agreement(25,012)Distributions to noncontrolling interests(2,046)Payments for tax withholdings from restricted stock vesting(1,324)Payments of contingent consideration and deferred purchase price from acquisitions—Net cash (used in) provided by financing activities(56,039)Net (decrease) increase in cash(56,097)Cash at beginning of period109,747 Noncash investing and financing activities:Unpaid equipment and other fixed asset purchases at end of period58,250Assets subject to operating lease obligations3,483Operating lease obligations(3,483) Finance lease obligations(7,388)Write-off of assets subject to finance lease obligations(678)Write-off of finance lease obligations678 (1)General Information categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The Sleep Health segment provides sleeptherapy equipment, supplies and related services (including CPAP and BiLevel services) to individuals for the treatment of obstructive sleep apnea. The Respiratory Health segment provides oxygen and home mechanical ventilation equipment and supplies and related chronic therapyservices to individuals for the treatment of respiratory diseases, such as chronic obstructive pulmonary disease and chronic respiratory failure. patients for the treatment of diabetes. The Wellness at Home segment provides home medical equipment and services to patients in their homesincluding those who have been discharged from acute care and other facilities. The segment tailors a service model to patients who are The interim consolidated financial statements are unaudited, but reflect all normal recurring adjustments that are, i